Patient characteristics associated with initiation of XR-naltrexone for opioid use disorder in clinical trials

Shulman, M., Hu, M.-C., Sullivan, M. A., Akerman, S. C., Fratantonio, J., Barbieri, V., Nunes, E. V., & Bisaga, A. (2022). Patient characteristics associated with initiation of XR-naltrexone for opioid use disorder in clinical trials. Drug and Alcohol Dependence, 233, 109343. https://doi.org/10.1016/j.drugalcdep.2022.109343
Authors:
Matisyahu Shulman
Mei-Chen Hu
Maria A. Sullivan
Sarah C. Akerman
James Fratantonio
Vincent Barbieri
Edward V. Nunes
Adam Bisaga
Affiliated Authors:
Matisyahu Shulman
Mei-Chen Hu
Maria A. Sullivan
Edward V. Nunes
Adam Bisaga
Author Keywords:
naltrexone
opioid use disorder
detoxification
Publication Type:
Article
Unique ID:
10.1016/j.drugalcdep.2022.109343
PMID:
Publication Date:
Data Source:
Scopus

Record Created: